AstraZeneca Pharmaceuticals LP is a biopharmaceutical company that researches, develops, and sells prescription drugs. Its filings show it lobbied on drug pricing and policies affecting Medicare and Medicaid, and specifically on provisions in the One Big Beautiful Bill (Public Law 119-21) as they relate to H.R.946, the Orphan Cures Act. It used the firm W Strategies, LLC and reported $320,000 across four filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DARREN WILLCOX
The latest disclosures for this client.
W STRATEGIES, LLC
Q1W STRATEGIES, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
W STRATEGIES, LLC
W STRATEGIES, LLC
Q3W STRATEGIES, LLC
Q2W STRATEGIES, LLC
Q1